Prescription drug · ANDA
brivaracetam NDC 70771-1755
Brivaracetam 25 mg/1 · Tablet, Film coated · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1755-4 | 70771175504 | 100 BLISTER PACK in 1 CARTON (70771-1755-4) / 1 TABLET, FILM COATED in 1 BLISTER PACK (70771-1755-7)Marketed from Feb 21, 2026 | |
| 70771-1755-6 | 70771175506 | 60 TABLET, FILM COATED in 1 BOTTLE (70771-1755-6)Marketed from Feb 21, 2026 | |
| 70771-1755-8 | 70771175508 | 180 TABLET, FILM COATED in 1 BOTTLE (70771-1755-8)Marketed from Feb 21, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- brivaracetam
- Generic name (nonproprietary)
- brivaracetam
- Active ingredients
- Brivaracetam — 25 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Zydus Lifesciences LimitedNDC labeler code 70771
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214501
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1755_43d4b6c1-4756-4199-90f9-d91d9c81c861SPL ID 43d4b6c1-4756-4199-90f9-d91d9c81c861SPL set ID 67c4db20-ba4d-4640-9e9c-6949b85429e3RxCUI 1739761, 1739768, 1739772, 1739776, 1739780UNII U863JGG2IA
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771175504followed by a unit qualifier and the quantityPackage 70771-1755-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 70771-1755
- What is NDC 70771-1755?
- 70771-1755 is the product NDC for brivaracetam, Brivaracetam 25 mg/1 tablet, film coated, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- brivaracetam.
- What is the active ingredient?
- Brivaracetam.
- Who is the labeler?
- Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for brivaracetam?
- 52 other product NDCs are listed under this name. See all brivaracetam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other brivaracetam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Brivaracetam | Brivaracetam 10 mg/mL | SolutionOral | Aurobindo Pharma Limited | 59651-995 | 59651-0995-03 |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-822 | — |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-823 | — |
| Brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-824 | — |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-825 | — |
| Brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-826 | — |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-068 | 84386-0068-60 |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-069 | 84386-0069-60 |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-071 | 84386-0071-60 |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-074 | 73190-0074-60 |
Other NDCs under ANDA 214501
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1588 |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1587 |
| brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1584 |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1585 |
| brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1586 |
| brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1754 |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1758 |
| brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1756 |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1757 |